High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients

Amyloid

Volumn 20, Issue 2, 2013, Pages 138-140

  Nakagawa, Michitaka ^a   Sekijima, Yoshiki ^a,b   Tojo, Kana ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Amyloid; Cardiac amyloidosis; Cardiomyopathy; Endomyocardial biopsy; Familial amyloid polyneuropathy; Senile systemic amyloidosis; Transthyretin

Indexed keywords

AMYLOID A PROTEIN; CONGO RED; PREALBUMIN;

ADULT; AGED; ARTICLE; CAUCASIAN; DNA SEQUENCE; ETHNIC DIFFERENCE; FEMALE; GENOTYPE; HEART AMYLOIDOSIS; HEART MUSCLE BIOPSY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

AGED; AMYLOID NEUROPATHIES, FAMILIAL; AMYLOIDOSIS; BIOPSY; FEMALE; HEART DISEASES; HUMANS; IMMUNOENZYME TECHNIQUES; JAPAN; MALE; MIDDLE AGED; MYOCARDIUM; POLYMERASE CHAIN REACTION; PREALBUMIN; PREVALENCE;

EID: 84878277073     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2013.790809     Document Type: Article

References (14)

1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898-909.
2. Coelho T, Maia LF, Martins da Silva A, Waddington Cruz M, Plante-Bordeneuve V, Lozeron P, Suhr OB, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 2012;79:785-92.
3. Sekijima Y, Dendle MA, Kelly JW. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid 2006;13:236-49.
4. Tojo K, Sekijima Y, Kelly JW, Ikeda SI. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloido-genesis. Neurosci Res 2006;56:441-9.
5. Miller SR, Sekijima Y, Kelly JW. Native state stabilization by nsaids inhibits transthyretin amyloidogenesis from the most common familial disease variants. Lab Invest 2004;84: 545-52.
6. Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, et al. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001;51:264-70.
7. Imada N. Pathological study on amyloidosis. Isolation and purification of amyloid fibril protein and biochemical and immunological analysis. Yamaguchi Med J 1981;30: 149-62.
8. Gustavsson A, Engstrom U, Westermark P. Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Pathol 1994;144:1301-11.
9. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-12.
10. Kyle RA, Spittell PC, Gertz MA, Li CY, Edwards WD, Olson LJ, Thibodeau SN. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;101: 395-400.
11. Ueda M, Horibata Y, Shono M, Misumi Y, Oshima T, Su Y, Tasaki M, et al. Clinicopathological features of senile systemic amyloid-osis: an ante-and post-mortem study. Mod Pathol 2011;24: 1533-44.
12. Cornwell III GG, Murdoch WL, Kyle RA, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75: 618-23.
13. Tanskanen M, Kiuru-Enari S, Tienari P, Polvikoski T, Verkkoniemi A, Rastas S, Sulkava R, et al. Senile systemic amyloidosis, cerebral amyloid angiopathy, and dementia in a very old Finnish population. Amyloid 2006;13:164-9.
14. Ikeda S, Sekijima Y, Tojo K, Koyama J. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. Amyloid 2011;18:211-15.